Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SCFAs alleviated steatosis and inflammation in mice with NASH induced by MCD
Mingjuan Deng, Fang Qu, Long Chen, et al.
Journal of Endocrinology (2020) Vol. 245, Iss. 3, pp. 425-437
Open Access | Times Cited: 151

Showing 1-25 of 151 citing articles:

Short-Chain Fatty-Acid-Producing Bacteria: Key Components of the Human Gut Microbiota
William G. Fusco, Manuel Bernabeu, Marco Cintoni, et al.
Nutrients (2023) Vol. 15, Iss. 9, pp. 2211-2211
Open Access | Times Cited: 423
Gut-liver axis: Pathophysiological concepts and clinical implications
Herbert Tilg, Timon E. Adolph, Michael Trauner
Cell Metabolism (2022) Vol. 34, Iss. 11, pp. 1700-1718
Open Access | Times Cited: 375
Functions of Gut Microbiota Metabolites, Current Status and Future Perspectives
Juan Liu, Yuzhu Tan, Hao Cheng, et al.
Aging and Disease (2022) Vol. 13, Iss. 4, pp. 1106-1106
Open Access | Times Cited: 257
Short-chain fatty acids in diseases
Dan Zhang, Yong‐Ping Jian, Yuning Zhang, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 211
Dietary fiber‐derived short‐chain fatty acids: A potential therapeutic target to alleviate obesity‐related nonalcoholic fatty liver disease
Shumin Zhang, Jingwen Zhao, Fei Xie, et al.
Obesity Reviews (2021) Vol. 22, Iss. 11
Closed Access | Times Cited: 147
Short chain fatty acids: key regulators of the local and systemic immune response in inflammatory diseases and infections
Lisa-Marie Ney, Maximilian Wipplinger, Martha Grossmann, et al.
Open Biology (2023) Vol. 13, Iss. 3
Open Access | Times Cited: 105
The Role of Gut–Liver Axis in Gut Microbiome Dysbiosis Associated NAFLD and NAFLD-HCC
Qian Song, Xiang Zhang
Biomedicines (2022) Vol. 10, Iss. 3, pp. 524-524
Open Access | Times Cited: 89
Host-microbiome interactions: Gut-Liver axis and its connection with other organs
Swadha Anand, Sharmila S. Mande
npj Biofilms and Microbiomes (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 89
The impact of microbiota-derived short-chain fatty acids on macrophage activities in disease: Mechanisms and therapeutic potentials
Hongliang Duan, Lijuan Wang, Mingmei Huangfu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115276-115276
Open Access | Times Cited: 67
Short-Chain Fatty Acids and Human Health: From Metabolic Pathways to Current Therapeutic Implications
Sonia Facchin, Luisa Bertin, Erica Bonazzi, et al.
Life (2024) Vol. 14, Iss. 5, pp. 559-559
Open Access | Times Cited: 56
Gut microbiota and metabolic biomarkers in metabolic dysfunction–associated steatotic liver disease
Qichen Long, Fengming Luo, Binghui Li, et al.
Hepatology Communications (2024) Vol. 8, Iss. 3
Open Access | Times Cited: 23
Plant polyphenols as natural bioactives for alleviating lipid metabolism disorder: Mechanisms and application challenges
Haiying Wei, Jialiang Rui, Xiaotong Yan, et al.
Food Research International (2025) Vol. 203, pp. 115682-115682
Closed Access | Times Cited: 3
The crucial function of gut microbiota on gut-liver repair
Yamei Wang, Yan He, Qianqian Zheng, et al.
hLife (2025)
Open Access | Times Cited: 3
When short-chain fatty acids meet type 2 diabetes mellitus: Revealing mechanisms, envisioning therapies
Cong Xie, Cong Qi, Jianwen Zhang, et al.
Biochemical Pharmacology (2025) Vol. 233, pp. 116791-116791
Open Access | Times Cited: 3
Inflammatory and fibrotic mechanisms in NAFLD—Implications for new treatment strategies
Youngmin A. Lee, Scott L. Friedman
Journal of Internal Medicine (2021) Vol. 291, Iss. 1, pp. 11-31
Open Access | Times Cited: 73
Short-chain fatty acid: An updated review on signaling, metabolism, and therapeutic effects
Kaliaperumal Rekha, Baskar Venkidasamy, Ramkumar Samynathan, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 64, Iss. 9, pp. 2461-2489
Closed Access | Times Cited: 70
Modulation of Short-Chain Fatty Acids as Potential Therapy Method for Type 2 Diabetes Mellitus
Ruiqi Tang, Lanjuan Li
Canadian Journal of Infectious Diseases and Medical Microbiology (2021) Vol. 2021, pp. 1-13
Open Access | Times Cited: 67
Probiotics alleviate autoimmune hepatitis in mice through modulation of gut microbiota and intestinal permeability
Qingqing Liu, Haixia Tian, Yongbo Kang, et al.
The Journal of Nutritional Biochemistry (2021) Vol. 98, pp. 108863-108863
Closed Access | Times Cited: 63
A potential therapeutic target in traditional Chinese medicine for ulcerative colitis: Macrophage polarization
Zhihua Yang, Shanshan Lin, Wanying Feng, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 58
The gut-lung axis in severe acute Pancreatitis-associated lung injury: The protection by the gut microbiota through short-chain fatty acids
Zhengjian Wang, Jin Liu, Fan Li, et al.
Pharmacological Research (2022) Vol. 182, pp. 106321-106321
Open Access | Times Cited: 54
A Systematic Review and Meta-analysis of Dietary Interventions Modulating Gut Microbiota and Cardiometabolic Diseases—Striving for New Standards in Microbiome Studies
Ilias Attaye, Moritz V. Warmbrunn, Aureline N.A.F. Boot, et al.
Gastroenterology (2022) Vol. 162, Iss. 7, pp. 1911-1932
Open Access | Times Cited: 40
Butyrate limits inflammatory macrophage niche in NASH
Ankita Sarkar, Priya Mitra, Abhishake Lahiri, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 5
Open Access | Times Cited: 40
The pathophysiology of MASLD: an immunometabolic perspective
Julian Schwärzler, Felix Grabherr, Christoph Grander, et al.
Expert Review of Clinical Immunology (2023) Vol. 20, Iss. 4, pp. 375-386
Closed Access | Times Cited: 31
Self-assembling polymer-based short chain fatty acid prodrugs ameliorate non-alcoholic steatohepatitis and liver fibrosis
Babita Shashni, Yuya Tajika, Yutaka Ikeda, et al.
Biomaterials (2023) Vol. 295, pp. 122047-122047
Closed Access | Times Cited: 25
Causal relationship between gut microbiota and gastrointestinal diseases: a mendelian randomization study
Kaiwen Wu, Qiang Luo, Ye Liu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top